Immune Checkpoint Inhibitors in Malignant Melanoma: Anti-PD-1, Anti-CTLA-4 and Anti-LAG-3 Therapies.
Saved in:
| Title: | Immune Checkpoint Inhibitors in Malignant Melanoma: Anti-PD-1, Anti-CTLA-4 and Anti-LAG-3 Therapies. |
|---|---|
| Authors: | Allen-Tejerina AM; Lister Hospital, Stevenage, UK., Giannakis P; Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK., Ho Lai Yau T; Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK., Hillyar CRT; Green Templeton College, University of Oxford, Oxford, UK., Rallis KS; Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK. hfy197@qmul.ac.uk.; Barts Cancer Institute, Queen Mary University of London, London, UK. hfy197@qmul.ac.uk. |
| Source: | Current oncology reports [Curr Oncol Rep] 2026 Mar 06; Vol. 28 (1). Date of Electronic Publication: 2026 Mar 06. |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: Current Science Country of Publication: United States NLM ID: 100888967 Publication Model: Electronic Cited Medium: Internet ISSN: 1534-6269 (Electronic) Linking ISSN: 15233790 NLM ISO Abbreviation: Curr Oncol Rep Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 41790359 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Immune Checkpoint Inhibitors in Malignant Melanoma: Anti-PD-1, Anti-CTLA-4 and Anti-LAG-3 Therapies. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Allen-Tejerina+AM%22">Allen-Tejerina AM</searchLink>; Lister Hospital, Stevenage, UK.<br /><searchLink fieldCode="AU" term="%22Giannakis+P%22">Giannakis P</searchLink>; Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK.<br /><searchLink fieldCode="AU" term="%22Ho+Lai+Yau+T%22">Ho Lai Yau T</searchLink>; Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK.<br /><searchLink fieldCode="AU" term="%22Hillyar+CRT%22">Hillyar CRT</searchLink>; Green Templeton College, University of Oxford, Oxford, UK.<br /><searchLink fieldCode="AU" term="%22Rallis+KS%22">Rallis KS</searchLink>; Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK. hfy197@qmul.ac.uk.; Barts Cancer Institute, Queen Mary University of London, London, UK. hfy197@qmul.ac.uk. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22100888967%22">Current oncology reports</searchLink> [Curr Oncol Rep] 2026 Mar 06; Vol. 28 (1). <i>Date of Electronic Publication: </i>2026 Mar 06. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Review – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Current+Science%22">Current Science </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>100888967 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1534-6269 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2215233790%22">15233790 </searchLink><i>NLM ISO Abbreviation: </i>Curr Oncol Rep <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41790359 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1007/s11912-026-01750-1 Languages: – Code: eng Text: English Titles: – TitleFull: Immune Checkpoint Inhibitors in Malignant Melanoma: Anti-PD-1, Anti-CTLA-4 and Anti-LAG-3 Therapies. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Allen-Tejerina AM – PersonEntity: Name: NameFull: Giannakis P – PersonEntity: Name: NameFull: Ho Lai Yau T – PersonEntity: Name: NameFull: Hillyar CRT – PersonEntity: Name: NameFull: Rallis KS IsPartOfRelationships: – BibEntity: Dates: – D: 06 M: 03 Text: 2026 Mar 06 Type: published Y: 2026 Identifiers: – Type: issn-electronic Value: 1534-6269 Numbering: – Type: volume Value: 28 – Type: issue Value: 1 Titles: – TitleFull: Current oncology reports Type: main |
| ResultId | 1 |